{"id":312145,"date":"2020-01-07T16:56:48","date_gmt":"2020-01-08T00:56:48","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/gracell-initiates-investigational-study-of-the-technological-breakthrough\/"},"modified":"2020-01-07T16:57:20","modified_gmt":"2020-01-08T00:57:20","slug":"%e4%ba%99%e5%96%9c%e7%94%9f%e7%89%a9%e5%95%9f%e5%8b%95-gc027-%e7%9a%84%e7%a0%94%e7%a9%b6","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2020\/01\/%e4%ba%99%e5%96%9c%e7%94%9f%e7%89%a9%e5%95%9f%e5%8b%95-gc027-%e7%9a%84%e7%a0%94%e7%a9%b6\/","title":{"rendered":"\u4e99\u559c\u751f\u7269\u555f\u52d5GC027\u7684\u7814\u7a76"},"content":{"rendered":"<p>\u81e8\u5e8a\u968e\u6bb5\u514d\u75ab\u7d30\u80de\u7642\u6cd5\u516c\u53f8\u4e99\u559c\u751f\u7269\u4eca\u5929\u5ba3\u4f48\u555f\u52d5GC027\u7684\u7814\u7a76\uff0cGC027\u662f\u4f7f\u7528TruUCAR\u2122\u958b\u767c\u7684\u7528\u65bc\u6cbb\u7642\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\uff08R \/ R\uff09\u7684T\u7d30\u80de\u60e1\u6027\u816b\u7624\u7684\u9996\u500b\u5019\u9078\u85e5\u7269\u3002<\/p>\n<p>T\u7d30\u80de\u6025\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5\u6216T-ALL\u662fALL\u7684\u4e00\u7a2e\u4fb5\u8972\u6027\u5f62\u5f0f\uff0c\u5b83\u5f71\u97ff\u767d\u7d30\u80de\u548c\u9aa8\u9ad3\u751f\u6210\u5065\u5eb7\u8840\u7d30\u80de\u7684\u80fd\u529b\u3002\u5927\u7d0415-20%\u7684ALL\u60a3\u8005\u60a3\u6709T-ALL\u3002\u5118\u7ba1T-ALL\u53ef\u4ee5\u901a\u904e\u5316\u5b78\u7642\u6cd5\u548c\u5e79\u7d30\u80de\u79fb\u690d\u6cbb\u7642\uff0c\u4f46\u5927\u7d0475%\u7684\u60a3\u8005\u5c07\u5728\u5169\u5e74\u5167\u5fa9\u767c\u3002T\u7d30\u80de\u6dcb\u5df4\u6bcd\u7d30\u80de\u6dcb\u5df4\u7624\uff08T-LBL\uff09\u662f\u53e6\u4e00\u7a2e\u7834\u58de\u6027T\u7d30\u80de\u60e1\u6027\u816b\u7624\u3002\u5c0d\u65bc\u767c\u751fR \/ R T-ALL\u6216T-LBL\u7684\u60a3\u8005\uff0c\u5e7e\u4e4e\u6c92\u6709\u6cbb\u7642\u9078\u64c7\u3002<\/p>\n<p>\u81ea\u9ad4CAR-T\u7642\u6cd5\u4f9d\u8cf4\u4e8e\u60a3\u8005\u81ea\u8eab\u7684T\u7d30\u80de\uff0c\u9019\u4e9b\u60a3\u8005\u7684T\u7d30\u80de\u5df2\u53d7\u5230\u5148\u524d\u7642\u6cd5\u7684\u5f71\u97ff\u3002\u56e0\u6b64\uff0c\u7d30\u80de\u8cea\u91cf\u548c\u529f\u6548\u4ecd\u7136\u503c\u5f97\u61f7\u7591\u3002\u7531\u5065\u5eb7\u6350\u737b\u8005\u7684T\u7d30\u80de\u88fd\u6210\u7684\u540c\u7a2eCAR-T\u7642\u6cd5\u7684\u7279\u9ede\u662f\u8cea\u91cf\u59cb\u7d42\u5982\u4e00\uff0c\u4e26\u5177\u6709\u63d0\u9ad8\u7642\u6548\u7684\u6f5b\u529b\u3002\u8207\u81ea\u9ad4CAR-T\u7d30\u80de\u4e0d\u540c\uff0c\u540c\u7a2e\u7570\u9ad4CAR-T\u7d30\u80de\u53ef\u4ee5\u88fd\u6210\u73fe\u6210\u7684\u7522\u54c1\uff0c\u9019\u610f\u5473\u8457\u60a3\u8005\u4e0d\u5fc5\u7b49\u5f85\u6f2b\u9577\u7684\u751f\u7522\u6642\u9593\u3002\u6b64\u5916\uff0c\u751f\u7522\u6210\u672c\u53ef\u4ee5\u5927\u5927\u964d\u4f4e\u3002\u540c\u7a2e\u7570\u9ad4CAR-T\u7642\u6cd5\u9084\u70ba\u75c5\u6bd2\u611f\u67d3\u548c\/\u6216\u5176\u4ed6\u7121\u6cd5\u4f7f\u7528\u81ea\u9ad4\u7d30\u80de\u7642\u6cd5\u7684\u75be\u75c5\u7684\u60a3\u8005\u63d0\u4f9b\u4e86\u91cd\u8981\u7684\u6cbb\u7642\u9078\u64c7\u3002<\/p>\n<p>\u57fa\u65bcTruUCAR\u2122\u7684GC027\u65e8\u5728\u6eff\u8db3\u4e0a\u8ff0\u672a\u6eff\u8db3\u7684\u9700\u6c42\u3002\u5b83\u7684\u7d30\u80de\u7531\u5065\u5eb7\u4f9b\u9ad4\u7684T\u7d30\u80de\u88fd\u6210\uff0c\u7d93\u904e\u57fa\u56e0\u7de8\u8f2f\uff0c\u4e26\u8207\u5d4c\u5408\u6297\u539f\u53d7\u9ad4\uff08CAR\uff09\u4e00\u8d77\u96e2\u9ad4\u63d2\u5165\uff0c\u53ef\u8207\u76ee\u6a19T\u60e1\u6027\u7d30\u80de\u7279\u7570\u6027\u7d50\u5408\u4e26\u6d88\u9664\u5b83\u5011\u3002\u8207\u884c\u696d\u9818\u5c0e\u8005\u73fe\u6210\u7684CAR-T\u8a2d\u8a08\u4e0d\u540c\uff0c\u4e99\u559c\u751f\u7269\u7684\u5c08\u6709\u5c08\u5229TruUCAR\u2122\u6280\u8853\u4e0d\u9700\u8981\u5171\u540c\u4f7f\u7528\u6297CD52\uff0c\u6297CD52\u662f\u4e00\u7a2e\u53ef\u6d88\u878d\u764c\u7d30\u80de\u540c\u6642\u8a98\u5c0e\u60a3\u8005\u9577\u671f\u514d\u75ab\u8017\u7aed\u7684\u7d30\u80de\u6bd2\u5291\u3002\u76f8\u53cd\uff0cGC027\u5229\u7528CRISPR\u57fa\u56e0\u7d44\u7de8\u8f2f\u7b56\u7565\uff0c\u6709\u671b\u907f\u514d\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GvHD\uff09\u4ee5\u53ca\u60a3\u8005\u514d\u75ab\u7cfb\u7d71\u5f15\u8d77\u7684\u79fb\u690d\u7269\u6392\u65a5\u3002<\/p>\n<p>\u4e99\u559c\u751f\u7269\u5275\u59cb\u4eba\u517c\u9996\u5e2d\u57f7\u884c\u5b98William CAO\u535a\u58eb\u8aaa\uff1a\u201c GC027\u7814\u7a76\u6027\u8a66\u9a57\u7684\u9996\u6b21\u63a8\u51fa\u662f\u4e99\u559c\u751f\u7269\u7684\u53e6\u4e00\u500b\u91cd\u8981\u91cc\u7a0b\u7891\u3002\u4e00\u65e6\u8a72\u6982\u5ff5\u5f97\u5230\u4e86\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u5145\u5206\u8b49\u660e\uff0c\u6211\u5011\u5c07\u7acb\u5373\u90e8\u7f72\u4e00\u7cfb\u5217TruUCAR\u2122\u7522\u54c1\u7684\u958b\u767c\uff0c\u4ee5\u6eff\u8db3\u5176\u4ed6\u91ab\u7642\u672a\u6eff\u8db3\u7684\u9700\u6c42\uff0c\u5305\u62ecB\u7d30\u80de\u60e1\u6027\u816b\u7624\u3002\u201d<\/p>\n<p>GC027\u662f\u4e00\u7a2e\u91dd\u5c0dT\u7d30\u80de\u60e1\u6027\u816b\u7624\u7684\u5be6\u9a57\u6027\u73fe\u6210CAR-T\u7d30\u80de\u7642\u6cd5\uff0c\u6e90\u81ea\u5065\u5eb7\u4f9b\u9ad4\u3002\u5065\u5eb7\u4f9b\u9ad4\u7d30\u80de\u7684\u4f7f\u7528\u512a\u5148\u4e8e\u60a3\u8005\u81ea\u8eab\u7684\u7d30\u80de\uff0c\u5177\u6709\u6539\u5584\u7642\u6548\uff0c\u6e1b\u5c11\u751f\u7522\u6642\u9593\u548c\u964d\u4f4e\u5546\u54c1\u6210\u672c\u7684\u6f5b\u529b\u3002<\/p>\n<p>T\u6dcb\u5df4\u7d30\u80de\u6027\u767d\u8840\u75c5\uff08T-ALL\uff09\u662fT\u7d30\u80de\u60e1\u6027\u816b\u7624\u7684\u4e00\u7a2e\u4fb5\u8972\u6027\u5f62\u5f0f\uff0c\u5177\u6709\u9aa8\u9ad3\u548c\u5916\u5468\u8840\u7684\u64f4\u6563\u6d78\u6f64\u3002 2015\u5e74\uff0cALL\u611f\u67d3\u4e86\u5168\u7403\u7d04876,000\u4eba\uff0c\u5168\u7403\u6b7b\u4ea1110,000\u4eba\u3002T-ALL\u7684\u7576\u524d\u6a19\u6e96\u7642\u6cd5\u662f\u5316\u5b78\u7642\u6cd5\u548c\u5e79\u7d30\u80de\u79fb\u690d\uff0c\u9019\u4e9b\u60a3\u8005\u4e2d\u7684\u5f88\u5927\u4e00\u90e8\u5206\u5c07\u5728\u5e38\u898f\u7642\u6cd5\u6cbb\u7642\u5f8c\u5169\u5e74\u5167\u5fa9\u767c\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gracell Biotechnologies Co., Ltd. (&#8220;Gracell&#8221;), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed using TruUCAR\u2122 to treat relapsed or refractory (R\/R) T-cell malignancies.<\/p>\n","protected":false},"author":9,"featured_media":312128,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-312145","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/312145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=312145"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/312145\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/312128"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=312145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=312145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=312145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}